STOCK TITAN

DTIL (NASDAQ: DTIL) insider to sell 8,854 shares under Rule 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

An insider of DTIL filed a notice of proposed sale under Rule 144 for 8,854 common shares, with an aggregate market value of 35,653.29. The shares are expected to be sold on 01/21/2026 on the NASDAQ through Fidelity Brokerage Services LLC. These shares were acquired on 01/20/2026 through restricted stock vesting from the issuer as compensation, rather than a cash purchase. The filing also reports that Dario J. Scimeca previously sold 665 common shares on 11/03/2025 for gross proceeds of 4,315.19. By signing the notice, the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does DTIL's latest Form 144 filing disclose?

The filing discloses that an insider plans to sell 8,854 shares of DTIL common stock with an aggregate market value of 35,653.29 on the NASDAQ under Rule 144.

Who is selling DTIL shares in this Form 144 and how many?

Dario J. Scimeca is identified as the seller, with a proposed sale of 8,854 common shares and a prior sale of 665 shares on 11/03/2025.

How were the DTIL shares in the Form 144 acquired?

The 8,854 DTIL common shares were acquired on 01/20/2026 through restricted stock vesting from the issuer as compensation, rather than through a cash purchase.

When and where are the DTIL shares expected to be sold?

The planned sale date is approximately 01/21/2026, with the shares to be sold on the NASDAQ through Fidelity Brokerage Services LLC in Smithfield, RI.

How many DTIL shares are outstanding according to the Form 144?

The Form 144 indicates there are 13,256,751 common shares of the issuer outstanding, providing a baseline for the size of the planned sale.

What prior DTIL stock sales are reported in the last 3 months?

The notice reports that 665 DTIL common shares were sold on 11/03/2025 for 4,315.19 in gross proceeds by Dario J. Scimeca.

Precision Biosciences

NASDAQ:DTIL

DTIL Rankings

DTIL Latest News

DTIL Latest SEC Filings

DTIL Stock Data

102.30M
22.56M
11.28%
44.24%
9.66%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
DURHAM